<?xml version="1.0" encoding="UTF-8"?>
<p>Other reports obtained potent nasal mucosal and systemic immune responses using intranasal delivery of whole, inactivated influenza vaccine powder formulations. Powder-formulated vaccine elicited a significant serum antibody response in rats that was at least as strong as the response from liquid vaccine administered by intranasal route or by intramuscular injection.
 <xref rid="b33-ijn-9-5603" ref-type="bibr">33</xref>,
 <xref rid="b34-ijn-9-5603" ref-type="bibr">34</xref> In these reports, a mouse model was used to assess vaccine efficacy mediated by nanoparticle delivery by intranasal delivery, against influenza virus, parainfluenza, hepatitis B, and 
 <italic>Streptococcus pneumoniae</italic> pathogens.
</p>
